T.YangF.PerryC.et al (2014)
According to the FDA, the data showed no increased risk of suicide, depression, anxiety, or related psychiatric effects compared to placebo, leading the agency to conclude that the existing warnings are not supported by the evidence
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
I favor shorter cycles with adequate breaks over marathon continuous use
Many patients report having access to dosing guidance and provider follow-up through the Direct Meds patient portal, which helps them titrate doses safely and manage side effects
Unlike exogenous GH, which can cause negative feedback suppression of the pituitary over time, CJC-1295 works through the pituitary rather than replacing it